Spravato Treatment


We are a Certified SPRAVATO™ Treatment Center

What is SPRAVATO™?

SPRAVATO™ is a prescription medicine, used along with an antidepressant taken by mouth, for treatment-resistant depression (TRD) in adults.  For additional safety information please visit SPRAVATO’s website here.

We outsource our Spravato services to Greenbrook TMS, housed within our facility.


If you’ve taken two or more oral antidepressants and still experience symptoms of depression, you might have treatment-resistant depression(TRD).

It might be time to talk to your doctor about a different treatment approach. See what makes SPRAVATO® different and learn more about other patients’ experiences with SPRAVATO®.


Proven Effective for Treatment-Resistant Depression

You may benefit from adding SPRAVATO® to your existing oral antidepressant if you’re an adult with major depressive disorder (MDD) who has had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD).

Adults with treatment-resistant depression who were part of a clinical study were given either a nasal esketamine spray or a placebo spray.

Those who added esketamine, the active ingredient in SPRAVATO®, to their oral antidepressant experienced a greater reduction of depressive symptoms at four weeks compared to those who received placebo plus an oral antidepressant.*

*Based on an overall score on a standardized rating scale.

If two or more oral antidepressants haven’t worked for you, ask your doctor if adding SPRAVATO® may be able to help.